Ontology highlight
ABSTRACT: Introduction
Anti-cyclic citrullinated peptide autoantibodies (anti-CCP) are the most specific serologic marker for rheumatoid arthritis (RA). Genetic polymorphisms in a citrullinating (or deiminating) enzyme, peptidyl arginine deiminase type IV (PADI4) have been reproducibly associated with RA susceptibility in several populations. We investigated whether PADI4 polymorphisms contribute to anti-CCP-negative as well as -positive RA, whether they influence disease severity (erosive joint status), and whether they interact with two major risk factors for RA, Human Leukocyte Antigen-DRB1 (HLA-DRB1) shared epitope (SE) alleles and smoking, depending on anti-CCP and erosive joint status.Methods
All 2,317 unrelated Korean subjects including 1,313 patients with RA and 1,004 unaffec
SUBMITTER: Bang SY
PROVIDER: S-EPMC2911908 | biostudies-literature | 2010
REPOSITORIES: biostudies-literature